Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.

Journal of applied physiology (Bethesda, Md. : 1985)

2008

https://researcherprofiles.org/profile/1460494

18292296

Zhao TC, Tseng A, Yano N, Tseng Y, Davol PA, Lee RJ, Lum LG, Padbury JF